Guanosine ameliorates positive symptoms of schizophrenia via modulating 5-HT1A and 5-HT2A receptors.
Year: 2021
Type: article
Abstract: -coupled PI3K/Akt signaling. Collectively, this study provides possible compounds and mechanisms for therapeutic effects on schizophrenia.
Source: PubMed Central
Authors: Yu Mao, Yao Xing, Jie Li, Dong Dong, Shoude Zhang, Zhenjiang Zhao, Jingli Xie, Rui Wang, Honglin Li
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3176583898
